Document is current
Any future updates will be listed below
-
Authors
Lange, Lotte Borg https://orcid.org/0009-0002-8973-9436
Bistrup, Claus
-
Funding
Funding for this research was provided by:
Dansk Nefrologisk Selskab (69500)
Nyreforeningen (50000)
Vissing Fonden (695000)
Karen Elise Jensens Fond (1978000)
Department of nephrology OUH (730000)
Steno Diabetes Center OUH (610000)
OUH PhD grant (628000)
Region Syddanmark (610000)
University of Southern Denmark
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 19 October 2025
First Online: 29 December 2025
Declarations
:
: The SGL-TX-MR study has been approved by the Clinical Trials Information System (CTIS) on 21 January 2025 (ID: 2024–513765-40–00). Prior to the initiation of any study-related procedures, written informed consent will be obtained from all participants in accordance with applicable ethical guidelines and regulatory requirements.
: This protocol does not include baseline or pilot data. No images, videos, or personally identifiable information about individual participants are included. Should such material be incorporated in future publications, written informed consent for publication will be obtained from the individual concerned and documented in accordance with applicable regulations. A model consent form used in the study can be provided upon request.
: The authors declare no competing interests.
